(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.25%) $79.15
(-0.44%) $2.03
(0.19%) $2 314.00
(0.64%) $27.00
(0.57%) $968.10
(-0.10%) $0.931
(-0.22%) $10.97
(-0.16%) $0.797
(1.52%) $92.51
@ $14.13
Issued: 14 Feb 2024 @ 09:30
Return: 2.55%
Previous signal: Feb 12 - 14:52
Previous signal:
Return: 10.05 %
Live Chart Being Loaded With Signals
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases...
Stats | |
---|---|
Today's Volume | 159 296 |
Average Volume | 96 293.00 |
Market Cap | 469.32M |
EPS | $0 ( 2024-03-28 ) |
Next earnings date | ( $-0.720 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -4.39 |
ATR14 | $0.0590 (0.41%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-05-10 | Oxford Science Enterprises Plc | Buy | 879 970 | Common Stock |
2024-03-01 | Svenstrup Niels | Buy | 83 000 | Stock Option (Right to Buy) |
2024-03-01 | Mcarthur James G | Buy | 300 000 | Stock Option (Right to Buy) |
2024-03-01 | Donnelly Noel | Buy | 144 000 | Stock Option (Right to Buy) |
2024-03-01 | Mellion Michelle L | Buy | 83 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
88.22 |
Last 93 transactions |
Buy: 15 622 342 | Sell: 5 738 999 |
Volume Correlation
PepGen Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
PepGen Inc. Correlation - Currency/Commodity
PepGen Inc. Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-1.18M (0.00 %) |
EPS: | $-3.30 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-1.18M (0.00 %) |
EPS: | $-3.30 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-493 000 (0.00 %) |
EPS: | $-2.91 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-3.53 |
Financial Reports:
No articles found.
PepGen Inc.
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also developing PGN-EDODM1, an EDO peptide-conjugated PMO for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators